BridgeMD
Tests treatment safety and results for PTSD - Post Traumatic Stress Disorder
Official title Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons
ClinicalTrials.gov ID: NCT06923423
What this study is testing
- What it's testing
- Addiction and trauma exposure are common among the 5.5 million people (1 in 47 adults) in the U.S. who are in prison or under supervision.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older
- Able to understand and speak English
- Able to give informed consent
- All items listed in "for all participants"
- Be currently incarcerated in one of the prisons that have partnered as study sites
You likely can't join if
- for prisoners (additional requirements assessed during pre-treatment assessments or indicated by prison staff; will result in being withdrawn from...
- Unable to provide any locator information for post-release assessments
- Determined to be releasing sooner than would allow the individual to complete CPT-CJ
- Determined to have an unavoidable scheduling conflict or facility restriction (e.g., disciplinary, medical) that would prevent participation in...
See the full eligibility criteria
- 18 years of age or older
- Able to understand and speak English
- Able to give informed consent
- All items listed in "for all participants"
- Be currently incarcerated in one of the prisons that have partnered as study sites
- Have met criteria for a drug use disorder in the year prior to their current incarceration (≥ 2 symptoms on a DSM-5 drug use disorder checklist)
- Have used drugs in the 30 days prior to their current incarceration
- Have a history of traumatic event exposure
- Endorse clinically significant posttraumatic stress symptoms (score ≥ 4 on the Primary Care PTSD Screen for DSM-5; PC-PTSD-5)
- Expect to be incarcerated for at least long enough to complete CPT-CJ as it is being implemented at the particular site (i.e., anticipated to be \~3 months, but will depend on dates associated with next available...
- Expect to be released from prison within 12 months following the end of treatment (i.e., within \~15 months of the pre-treatment assessment)
- Willing to consent to randomization to treatment condition
- for prisoners (additional requirements assessed during pre-treatment assessments or indicated by prison staff; will result in being withdrawn from the study prior to randomization by the PI):
- Unable to provide any locator information for post-release assessments
- Determined to be releasing sooner than would allow the individual to complete CPT-CJ
- Determined to have an unavoidable scheduling conflict or facility restriction (e.g., disciplinary, medical) that would prevent participation in CPT-CJ. Of note, if the scheduling conflict or facility restriction is...
The study team makes the final eligibility decision.
Where it's taking place
- Little Rock, Arkansas, United States
- Osceola, Arkansas, United States
- Texarkana, Arkansas, United States
- West Memphis, Arkansas, United States
- Bismarck, North Dakota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Little Rock, Arkansas, United States; Osceola, Arkansas, United States; Texarkana, Arkansas, United States; West Memphis, Arkansas, United States; Bismarck, North Dakota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.